Phage-displayed mimotopes recognizing a biologically active anti-HIV-1 gp120 murine monoclonal antibody.

No abstract is available for this paper.

• Publication year

  2002

• Venue

  Journal of Acquired Immune Deficiency Syndromes

• Publication date

  2002-10-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1097/00126334-200210010-00004PMID 12394792
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Identification of peptide sequences specific for serum antibodies from human papillomavirus-infected patients using phage display libraries.

  2001cited by this paper
• Evidence for a Correlation Between Antibody-Dependent Cellular Cytotoxicity-Mediating Anti-HIV-1 Antibodies and Prognostic Predictors of HIV Infection

  2001cited by this paper
• Relationship between Antibody-Dependent Cellular Cytotoxicity, Plasma HIV Type 1 RNA, and CD4+ Lymphocyte Count

  2001cited by this paper
• Murine Monoclonal Antibodies Biologically Active against the Amino Region of HIV-1 gp120: Isolation and Characterization

  2000cited by this paper
• Identification of mimotopes of platelet autoantigens associated with autoimmune thrombocytopenic purpura.

  2000cited by this paper
• Selection of HIV-specific immunogenic epitopes by screening random peptide libraries with HIV-1-positive sera.

  1999cited by this paper
• Characterization of cerebrospinal fluid antibody specificities in neurocysticercosis using phage display peptide library.

  1999cited by this paper
• Antibody-Dependent Cellular Cytotoxicity Directed against Cells Expressing Human Immunodeficiency Virus Type 1 Envelope of Primary or Laboratory-Adapted Strains by Human and Chimpanzee Monoclonal Antibodies of Different Epitope Specificities

  1998cited by this paper
• Immune responses to human immunodeficiency virus (HIV) type 1 induced by canarypox expressing HIV-1MN gp120, HIV-1SF2 recombinant gp120, or both vaccines in seronegative adults. NIAID AIDS Vaccine Evaluation Group.

  1998cited by this paper
• Anti-Human Immunodeficiency Virus Type 1 Human Monoclonal Antibodies that Bind Discontinuous Epitopes in the Viral Glycoproteins Can Identify Mimotopes from Recombinant Phage Peptide Display Libraries

  1997cited by this paper
• A novel antibody-dependent cellular cytotoxicity epitope in gp120 is identified by two monoclonal antibodies isolated from a long-term survivor of human immunodeficiency virus type 1 infection

  1997cited by this paper
• Antibody‐dependent cellular cytotoxicity in HIV infections

  1996cited by this paper
• HIV-1 gp120-specific antibody-dependent cell-mediated cytotoxicity correlates with rate of disease progression.

  1996cited by this paper
• Neutralizing and infection-enhancing antibody responses to human immunodeficiency virus type 1 in long-term nonprogressors.

  1996cited by this paper
• Peptides isolated from random peptide libraries on phage elicit a neutralizing anti‐HIV‐1 response: analysis of immunological mimicry

  1996cited by this paper
• Screening a monoclonal antibody with a fusion‐phage display library shows a discontinuity in a linear epitope within pres1 of hepatitis B virus

  1995cited by this paper
• Epitope mapping of anti-HIV and anti-HCV monoclonal antibodies and characterization of epitope mimics using a filamentous phage peptide library.

  1995cited by this paper
• Defining critical residues in the epitope for a HIV-neutralizing monoclonal antibody using phage display and peptide array technologies.

  1993cited by this paper
• Identification of HIV vaccine candidate peptides by screening random phage epitope libraries.

  1993cited by this paper
• Role of antibody-dependent cellular cytotoxicity in defense against herpes simplex virus infections.

  1991cited by this paper
• Antibody-dependent cellular cytotoxicity against HIV-1 in sera of immunized chimpanzees.

  1991cited by this paper
• A monoclonal antibody to human immunodeficiency virus type 1 which mediates cellular cytotoxicity and neutralization

  1990cited by this paper
• Random peptide libraries: a source of specific protein binding molecules.

  1990cited by this paper
• Antibodies mediating cellular cytotoxicity and neutralization correlate with a better clinical stage in children born to human immunodeficiency virus-infected mothers.

  1990cited by this paper
• Possible Beneficial Effects of Neutralizing Antibodies and Antibody-Dependent, Cell-Mediated Cytotoxicity in Human Immunodeficiency Virus Infection

  1990cited by this paper
• Peptides on phage: a vast library of peptides for identifying ligands.

  1990cited by this paper
• Searching for peptide ligands with an epitope library.

  1990cited by this paper
• Two receptors are required for antibody-dependent enhancement of human immunodeficiency virus type 1 infection: CD4 and Fc gamma R

  1990cited by this paper
• The FC and not CD4 receptor mediates antibody enhancement of HIV infection in human cells.

  1989cited by this paper
• The Fc and not CD4 receptor mediates antibody enhancement of HIV infection in human cells.

  1989cited by this paper
• Cellular anti-GP120 cytolytic reactivities in HIV-1 seropositive individuals.

  1988cited by this paper
• Human T-cell lymphotropic virus IIIB glycoprotein (gp120) bound to CD4 determinants on normal lymphocytes and expressed by infected cells serves as target for immune attack.

  1987cited by this paper
• Immunotherapy of murine leukemia. IX. The requirement for the Fc portion of antibody for successful passive serum therapy of Friend leukemia virus-induced disease.

  1983cited by this paper
• Immunotherapy of a murine leukemia virus-infected, chemically induced murine sarcoma with antiviral antibodies.

  1982cited by this paper

• Self-assembled monolayers to create novel surfaces utilising peptides identified by phage display for in vitro study of cancer stem cells

  2019cites this paper
• A Partial E3 Deletion in Replication-Defective Adenoviral Vectors Allows for Stable Expression of Potentially Toxic Transgene Products

  2016cites this paper
• Intracellular mannose binding lectin mediates subcellular trafficking of HIV-1 gp120 in neurons.

  2014cites this paper
• A Modern Biopharmaceutical to Treat AIDS – Challenges in Designing HIV Env Immunogens for Developing a Vaccine

  2013cites this paper
• λ Phage Nanobioparticle Expressing Apoptin Efficiently Suppress Human Breast Carcinoma Tumor Growth In Vivo

  2013cites this paper
• Phages and HIV-1: From Display to Interplay

  2012cites this paper
• Ability of antibodies specific to the HIV-1 envelope glycoprotein to block the fusion inhibitor T20 in a cell-cell fusion assay.

  2012cites this paper
• Designing Immunogens for Vaccine Development in Reference to HIV

  2011cites this paper
• Residues in the membrane-spanning domain core modulate conformation and fusogenicity of the HIV-1 envelope glycoprotein.

  2010cites this paper
• HIV–1 Antigens in Neurons of Cocaine-Abusing Patients

  2008cites this paper
• Challenges in designing HIV env immunogens for developing a vaccine

  2008cites this paper
• Defining carbohydrate antigens as HIV vaccine candidates.

  2007cites this paper
• Role of Neutralizing Antibodies in Protective Immunity Against HIV

  2005cites this paper
• Mimotopes of conformational epitopes in fibrillar beta-amyloid.

  2004cites this paper
• An adenoviral type 5 vector carrying a type 35 fiber as a vaccine vehicle: DC targeting, cross neutralization, and immunogenicity.

  2004cites this paper
• Neutralizing antibody responses to HIV: role in protective immunity and challenges for vaccine design

  2004cites this paper
• Expressed on Cell Surface via Humoral Immune Epitope of Nef Protein Antibody-Dependent Cellular Cytotoxicity

  2004cites this paper
• Antibody-Dependent Cellular Cytotoxicity via Humoral Immune Epitope of Nef Protein Expressed on Cell Surface1

  2004cites this paper